Distribution Curve, page-33

I think Caketin is correct. These folks can't pass on any sensitive information that has not been communicated to the general market. The last communication I had with the company (about 4 weeks back) indicated:

(a) they were arranging to have results from the various sites gathered and analysis commenced in parallel, rather than do things sequentially. I guess that could mean that the trial has completed (or is substantially completed) at some sites, but perhaps not at others.
(b) While the above was a more costly way of doing things, it would save some time in being able to release top-line results of the overall trial. This release was certainly anticipated to be made by end September.